Ca 2+ -Dependent Rapid Ca 2+ Sensitization of Contraction in Arterial Smooth Muscle
2006/12/08 by George J. Dimopoulos, Shingo Semba, Kazuyo Kitazawa +2 · 29 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Protein Kinase Regulation and GTPase Signaling #Ion channel regulation and function #Cardiomyopathy and Myosin Studies
paper · pdf · doi:10.1161/01.res.0000253902.90489.df
Abstract
Ca(2+) ion is a universal intracellular messenger that regulates numerous biological functions. In smooth muscle, Ca(2+) with calmodulin activates myosin light chain (MLC) kinase to initiate a rapid MLC phosphorylation and contraction. To test the hypothesis that regulation of MLC phosphatase is involved in the rapid development of MLC phosphorylation and contraction during Ca(2+) transient, we compared Ca(2+) signal, MLC phosphorylation, and 2 modes of inhibition of MLC phosphatase, phosphorylation of CPI-17 Thr38 and MYPT1 Thr853, during alpha(1) agonist-induced contraction with/without various inhibitors in intact rabbit femoral artery. Phenylephrine rapidly induced CPI-17 phosphorylation from a negligible amount to a peak value of 0.38+/-0.04 mol of Pi/mol within 7 seconds following stimulation, similar to the rapid time course of Ca(2+) rise and MLC phosphorylation. This rapid CPI-17 phosphorylation was dramatically inhibited by either blocking Ca(2+) release from the sarcoplasmic reticulum or by pretreatment with protein kinase C inhibitors, suggesting an involvement of Ca(2+)-dependent protein kinase C. This was followed by a slow Ca(2+)-independent and Rho-kinase/protein kinase C-dependent phosphorylation of CPI-17. In contrast, MYPT1 phosphorylation had only a slow component that increased from 0.29+/-0.09 at rest to the peak of 0.68+/-0.14 mol of Pi/mol at 1 minute, similar to the time course of contraction. Thus, there are 2 components of the Ca(2+) sensitization through inhibition of MLC phosphatase. Our results support the hypothesis that the initial rapid Ca(2+) rise induces a rapid inhibition of MLC phosphatase coincident with the Ca(2+)-induced MLC kinase activation to synergistically initiate a rapid MLC phosphorylation and contraction in arteries with abundant CPI-17 content.
Cited by
- PKC-mediated cerebral vasoconstriction: Role of myosin light chain phosphorylation versus actin cytoskeleton reorganization
- Failure of Bay K 8644 to induce RhoA kinase‐dependent calcium sensitization in rabbit blood vessels
- Functional remodelling of arterial endothelium during early postnatal development in rats
- Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation
- Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor. [europepmc]
- Smooth muscle signalling pathways in health and disease. [europepmc]
- Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle. [europepmc]
- Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation. [europepmc]
- G protein-mediated Ca²+-sensitization of CPI-17 phosphorylation in arterial smooth muscle. [europepmc]
- An integrated mathematical model of thrombin-, histamine-and VEGF-mediated signalling in endothelial permeability. [europepmc]
- The importance of Rho-associated kinase-induced Ca2+ sensitization as a component of electromechanical and pharmacomechanical coupling in rat ureteric smooth muscle. [europepmc]
- Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells. [europepmc]
- Altered contractile phenotypes of intestinal smooth muscle in mice deficient in myosin phosphatase target subunit 1. [europepmc]
- Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells. [europepmc]
- Impact of heating on passive and active biomechanics of suspended cells. [europepmc]
- The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease. [europepmc]
- Sevoflurane and isoflurane inhibit KCl-induced Class II phosphoinositide 3-kinase α subunit mediated vasoconstriction in rat aorta. [europepmc]
- Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction. [europepmc]
- Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA. [europepmc]
- Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1). [europepmc]
- Mechanisms underlying the pathogenesis of hyper-contractility of bronchial smooth muscle in allergic asthma. [europepmc]
- Preventative effects of a HIF inhibitor, 17-DMAG, on partial bladder outlet obstruction-induced bladder dysfunction. [europepmc]
- RhoA/rho-kinase, nitric oxide and inflammatory response in LIMA during OPCABG with isoflurane preconditioning. [europepmc]
- Angiotensin II-Regulated Autophagy Is Required for Vascular Smooth Muscle Cell Hypertrophy. [europepmc]
- PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins. [europepmc]
- Phosphorylation Sites in Protein Kinases and Phosphatases Regulated by Formyl Peptide Receptor 2 Signaling. [europepmc]
- Defective Autophagy in Vascular Smooth Muscle Cells Alters Vascular Reactivity of the Mouse Femoral Artery. [europepmc]
- Acute glucose influx-induced mitochondrial hyperpolarization inactivates myosin phosphatase as a novel mechanism of vascular smooth muscle contraction. [europepmc]
- Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions. [europepmc]
Related